This event will bring together global concerns such as climate change and human health, shedding light on the nexus between increasing man-made natural adversities and growing health needs. It will discuss why future projects aimed at strengthening and/or developing the health sector in the Philippines should have community engagement and climate resilience as their primary objectives.
EIT Health joins the European Patients’ Forum (EPF) and other key players in launching the “Data Saves Lives” initiative on 12 November 2019 at the EPF Congress in Brussels.
Early dialogue and frequent interactions between medicine developers, regulators, health technology assessment bodies (HTAs) and patients can play a key role in delivering robust data needed to enable accelerated access of patients to highly innovative therapies that address unmet medical needs. The chair of EMA’s committee for advanced therapies (CAT), Martina Schussler-Lenz, the chair of EMA’s human medicines committee (CHMP), Harald Enzmann, and the head of EMA’s scientific advice office, Spiros Vamvakas describe these interactions through the example of the recent authorisation of Zynteglo (lentiglobin) in a perspective piece published in Clinical Pharmacology & Therapeutics.
On November 21-22, a couple of month after the first-ever High-Level Meeting on Universal Health Coverage (UHC) is taking place during the UN General Assembly, POLITICO is bringing the Annual Health Care Summit to Amsterdam — a world-renowned life science innovation center and the new home of the European Medicines Agency — for what will be its fourth successful edition. We’ll gather the industry’s top minds together with key policymakers, scientists, business leaders and patient representatives to debate on the policy and cooperative innovations to better public health for the whole of society.
By European Patients Forum
“The patient is a hugely untapped resource in the health system. The Congress will stimulate debate and discussion, building on the premise that the patient’s own unique experiential knowledge, can impact on various areas” [Marco Greco, EPF President].
By the European Association of Hospital Pharmacists (EAHP)
The 2019 Medicines Shortages Survey seeks to investigate some of the reasons for medicines shortages in hospitals as well as the impact on patients. In addition, it will identify solutions in place as well as best practices currently applied at local, regional and national level.
The survey targets hospital pharmacists, nurses, physicians, other healthcare professionals working in the hospital environment and patients.
Join Bayer to discuss how innovative medicines can support societal efforts against Cancer.
Study presented at the EMPL Committee meeting on 5 November 2019.